Methicillin-resistant Staphylococcus aureus (MRSA) is a Gram-positive bacteria that is resistant to several antibiotics. The CDC estimates that approximately 1 in 50 people in the U.S. are colonized with MRSA in their nose.1 Further, individuals who are colonized are four times more susceptible to infection.2 MRSA is commonly found in hospitals and healthcare facilities, where it can cause severe health problems, including pneumonia, bloodstream infections, sepsis, and even death.1
The ARIES® MRSA Assay aids in the prevention and control of MRSA infections in healthcare settings. To increase the confidence in a MRSA call, the ARIES® MRSA Assay includes mecA/mecC resistance gene detection, and SCCmec and orfX targets to ensure the resistance gene is associated with and present in S. aureus.
|ARIES® MRSA Assay Performance Compared to Direct Culture and Enriched Culture|
|ARIES® MRSA Assay||97/104 (93.3%)||1,550/1,658 (93.5%)|
|Refer to Package Insert for additional details: Luminex Corporation | ARIES® MRSA Assay Kit Package Insert.|
The operator transfers a portion of the sample from the ESwab™ container to the Sample Processing Tube, vortexes, and transfers the sample to the cassette. The cassette is placed into an ARIES® Magazine, loaded to the ARIES® System, and the run is initiated.
Prepare the sample using the provided sample processing tube
Load the sample into the cassette
Insert up to six cassettes into the magazine
Insert the magazines into the instrument
Review & release results
|Luminex Online Order Management|
|Product Name||Kit Size||Registration Status||Part Number|
|ARIES® MRSA Assay Kit
|ARIES® MRSA Assay Protocol File Kit
(one time order only)
|ARIES® Two Module System
|ARIES® M1 System
*Assay Kit 50-10045 comes with 25 sample processing tubes. Additional processing tubes may be ordered, if desired, using this part number.
|ARIES® MRSA Assay Resources|
|ARIES® MRSA Assay|
|ARIES® Lean Lab White Paper: Delivering More with Less|
For In Vitro Diagnostic Use. Products are region specific and may not be approved in some countries/regions. Please contact Luminex at [email protected] to obtain the appropriate product information for your country of residence.
The ARIES® MRSA Assay is an integrated, real-time, polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection of methicillin–resistant Staphylococcus aureus (MRSA) DNA from nasal swabs in patients at risk for nasal colonization.
The ARIES® MRSA Assay is intended to aid in the prevention and control of MRSA infections in healthcare settings.
The assay is not intended to guide, diagnose, or monitor treatment for MRSA infections. It is not intended to provide results of susceptibility to oxacillin/methicillin. A negative result does not preclude MRSA nasal colonization.
Concomitant cultures are necessary to recover organisms for epidemiological typing or for further susceptibility testing.
The ARIES® MRSA Assay is indicated for use with ARIES® Systems.
ARIES® Systems are class 1(I) laser products.
Validation of LIS compatibility must be performed by the end user.